Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial Retatrutide, Eli Lillys next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight
Written by Olivia Farrow, RD, MHSc Reviewed by Krista Kolodziejzyk, RD, MPH, MBA and Maria Dellanina, RDN Quick Links If you are a dietitian working in client nutrition counseling, chances are youve had at least one client mention GLP-1 medications in the past few months
Youll be more likely to commit to the process and see results Two paid features of Cronometer that really stand out for macro counters: Nutrient oracle You can find the best foods for specific nutrients (helpful for when you are running short of a macro) Target Scheduler Allows different macro targets for different days (very useful for those with workout macros and rest day macros)
Affordability Tips: Ask About Generic Versions: Generic versions of semaglutide are expected to be launched after the patent expires in March 2026
